SHARE THIS VIDEO —
Mylan CEO Defends Price of EpiPen, Insists Company Isn't Price-Gouging
This version of Mmvo42773061876 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
Heather Bresch, the CEO of Mylan Pharmaceuticals and the daughter of a prominent US senator, insisted that the rising price of the EpiPen is the result of the health care system in the U.S.
NBC News Clone will keep curating essential reads for you — simplified and optimized.
